ACH — Accendra Health Cashflow Statement
0.000.00%
Last trade - 00:00- $273.65m
- $2.04bn
- $2.76bn
Annual cashflow statement for Accendra Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 222 | 22.4 | -41.3 | -363 | -1,101 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 88.1 | -1.6 | -16.6 | 301 | 737 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -246 | 102 | 535 | -15.1 | 65.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 124 | 325 | 741 | 161 | -102 |
| Capital Expenditures | -49.7 | -167 | -208 | -228 | -201 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -3.94 | -1,638 | 70.6 | 112 | 346 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -53.6 | -1,804 | -137 | -117 | 144 |
| Financing Cash Flow Items | -47.3 | -85.4 | -0.637 | -23.4 | -5.24 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -129 | 1,497 | -417 | -268 | 188 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -62.5 | 14.2 | 187 | -224 | 233 |